Climb Bio所有资讯

Climb Bio | 4：持股变动声明-高管 Pimblett Emily

12/21 05:22

Climb Bio | SC 13G/A：超过5%持股股东披露文件(修正)-Deep Track Capital, LP(3.23%),Deep Track Biotechnology Master Fund, Ltd.(3.23%)等

11/14 22:31

Climb Bio | 4：持股变动声明-董事 WILLIAMS DOUGLAS E

11/13 06:52

Climb Bio | 3：首次持股声明-董事 WILLIAMS DOUGLAS E

11/13 06:38

Eliem Therapeutics | 4：持股变动声明-高管 Pimblett Emily

09/21 09:57

Eliem Therapeutics | 4：持股变动声明-高管 Kaplan Brett

08/27 05:51

Eliem Therapeutics | 3：首次持股声明-高管 Kaplan Brett

08/27 05:41

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)

08/17 04:28

Eliem Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)

08/15 04:12

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/24 05:10

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/19 23:15

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/18 06:12

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/17 06:17

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/12 08:49

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/10 04:46

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

07/04 02:46

Eliem Therapeutics | D：发行公告

07/03 04:44

Eliem Therapeutics | D：发行公告

07/03 04:43

Eliem Therapeutics | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(5.85%),Deep Track Biotechnology Master Fund, Ltd.(5.85%)等

07/03 04:09

Eliem Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

07/02 09:34